Scientists from EPFL and ETHZ have developed a powerful tool for exploring and determining the inherent biological differences between individuals, which overcomes a major hurdle for personalized medicine.
One of the biggest obstacles in successfully treating metabolic disorders such as diabetes, obesity, fatty liver etc, is the variation in the way patients respond to medication. The key to this variation lies in the inherent biological differences between individuals, which cannot all be explained genetically. At the same time, this variation makes it very difficult to develop “standard” treatments for certain diseases. In a groundbreaking initiative, EPFL and ETHZ scientists have developed a strategy that can define and explain metabolic differences between individuals, essentially paving the way for precision medicine. The work, which also highlights significant issues with animal-based drug studies, is published in Science.
We are increasingly learning that medical interventions can be more successful when they are tailored to the specific profile of the individual patient. The problem is that defining that profile is extremely difficult, as it involves information on the person’s genome, proteins, fats, and all sorts of other layers of biology that make up their tissues and body. And so far, the only differences that we have been seriously taking into account are those found between genes.
This is what the labs of Johan Auwerx at EPFL and Ruedi Aebersold at ETH Zurich set out to solve with their recently published study. Looking at 40 different mice strains, the researchers successfully connected the variation between individuals’ genomes to the variation between their proteomes — their full set of proteins. In this way, they took a giant leap in profiling the biology of a particular individual.
“There is a black box between a patient’s genome and their disease,” says Johan Auwerx, whose lab handled the genome side of the study. “What we have done here is find a way to fill the black box by obtaining information on the patient’s proteome.”
“It’s much more complex to measure the set of proteins than to sequence the entire genome,” says Yibo Wu, co-lead author of the study. The scientists used protein data from mice, which they obtained from a new mass spectrometry technique that Aebersold’s group developed, known as SWATH-MS. This is a technique that combines the advantages of high-throughput mass spectrometry with high reproducibility and consistency. In short, it is able to identify thousands of different proteins in hundreds of samples much faster and accurately than conventional techniques, allowing the researchers to measure the concentrations of a broad spectrum of liver proteins in the mice.
The researchers measured a total of 2,600 different proteins from tissue samples of 40 mice strains, all of which came from the same two ancestors, meaning that they were genetically related to each other. “We wanted to keep the genetics simple in order to observe differences in the impact of environment (diet) on the proteome, other layers of biology, and their predisposition to develop diseases,” says Auwerx.
The mice were divided into groups of representing each of the 40 strains, and the groups were fed either a high-fat diet – essentially junk food – or a healthy, low-fat diet. Over a few weeks, the scientists charted the mice’s physiological data, and tested how fast they could gain weight on the junk-food diet and lose weight by exercising. Despite their similar genetic make-up, the mice on the high-fat diet showed varied responses to diet and exercise. For example, some developed metabolic disorders like fatty liver, while others did not.
The researchers then combined the physiological data with data for their genome, their proteome, and their transcriptome, which is essentially their full set of RNAs — another biological “layer” in the black box. Through this combination, the scientists were able to better understand the role several proteins play when it comes to metabolizing fat and producing energy from it.
“Like the mouse strains in this study, each patient with a disease is genetically different”, says Ruedi Aebersold. “The approach we used in the mouse cohort can now be applied one-for-one in research on human diseases, and particularly for personalized medicine.” The SWATH-MS approach is now ready to use in human cohort studies, as the researchers in his group have produces a corresponding database for thousands of human proteins.
“The aim here is to be able to customise medical intervention for each patient based on their individual biological makeup, the ‘black box’,” says Auwerx. In this vein, his group is now looking at specific drugs that can be used more effectively with this approach to treat metabolic disorders.
Learn more: New tool brings personalized medicine closer
The Latest on: Personalized medicine
via Google News
The Latest on: Personalized medicine
- Next Generation Sequencing (NGS) Market Size, Research, Growth Forecast to surpass USD 16.6 billion by 2025on February 3, 2020 at 4:15 am
Market Study Report Has Added A New Report On Next Generation Sequencing (NGS) Market That Provides A Comprehensive Review Of This Industry With Respect To The Driving Forces Influencing The Market ...
- Safer and more affordable medicine for all? How Pharmacogenomics may level the playing fieldon January 30, 2020 at 10:34 pm
A trained molecular biologist, immunologist, and the former Head of Genomics Science and Biologics at Sanofi, Tocci has worked in drug discovery and pre-clinical development for most of his career, ...
- New resources in precision medicine that every doctor should know abouton January 29, 2020 at 8:12 am
Precision medicine, or personalized medicine as it is sometimes referred to, is a most significant and promising healthcare trend. The National Institutes of Health (NIH) defines precision medicine as ...
- Global Personalized Medicine Market 2020-Laboratory Corporation of America,Quest Diagnostics,Abbott, Becton Dickinson and Coon January 29, 2020 at 2:49 am
Eon Market Research has announced the inclusion of a new market research report to its comprehensive collection of research studies. The 115-page research report, titled "Global Personalized Medicine ...
- Genomic Profiling for Precision Medicine: Interview with David Spetzler, Caris Life Scienceson January 28, 2020 at 1:54 pm
Personalized medicine holds enormous potential in improving patient outcomes, but has been limited by the complexity of contextualizing the molecular or genetic signatures of diseased tissues, such as ...
- Direct-to-consumer genetic tests attempt to capture the zeitgeist of personalized medicineon January 28, 2020 at 3:06 am
We are practicing medicine at the intersection of expectation and limitation ... holistic guidance — and deliver what we as clinicians know is truly personalized care.
- Researchers identify opportunities to advance genomic medicineon January 27, 2020 at 1:52 pm
Cho, MD, Dean of Translational Genetics at the Icahn School of Medicine at Mount Sinai, Director of The Charles Bronfman Institute for Personalized Medicine, and a co-author of the report. "Applying ...
- Addressing Disparities Will Advance Genomics, Precision Medicineon January 27, 2020 at 7:53 am
Cho, MD, Dean of Translational Genetics at the Icahn School of Medicine at Mount Sinai, Director of The Charles Bronfman Institute for Personalized Medicine, and a co-author of the report. “Applying ...
- Artificial Intelligence in Medicine Market Advanced Technology and New Innovations by 2025 – InSilico Medicine, Globavir Bioscienceson January 27, 2020 at 5:02 am
Based on application, the market is categorized into drug discovery & repurposing, clinical research trial, personalized medicine, and others. Based on region, it is analyzed across North America, ...
- Global Personalized Medicine Market revenue to hit USD 3466 Million By 2024on January 24, 2020 at 1:29 am
Zion Market Research added a new report "Global Personalized Medicine Market Set For Rapid Growth To Reach Around USD 3466 Million By 2024" in its database, which provides an expert and in-depth ...
via Bing News